Signase is a cancer therapeutics company developing small molecule inhibitors of a critical cell replication pathway to inhibit tumor growth
Signase is a cancer therapeutics company developing small molecule inhibitors of a critical cell replication pathway to inhibit tumor growth. Signase was spun out of the M. D. Anderson Cancer Center.